Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
October 2005
Sun Mon Tue Wed Thu Fri Sat
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31
Saskatchewan Winters Last updated: Mon 04 Feb 2008 11:19 PM CST
Saskatchewan Blizzard
View Article  Three-year Study on Copaxone

Three-year Study Shows Good Efficacy and Safety for Copaxone in MS: Presented at ECTRIMS


By Bruce Sylvester THESSALONIKI, GREECE -- October 5, 2005 -- A 3-year study of patients with ...   more »

View Article  trial of the tolerability of Rebif
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis.

    Mikol D, Lopez-Bresnahan M, Taraskiewicz S, ...   more »
View Article  trial of an energy conservation course for persons with MS

Randomized controlled trial of an energy conservation course for persons with multiple sclerosis.

    Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P.

    Program in Occupational Therapy, University ...   more »

View Article  employment status changes in individuals with MS

Factors related to employment status changes in individuals with multiple sclerosis.

    Smith MM, Arnett PA.

    Psychology Department, Penn State University, 522 Bruce V. Moore Bldg., College of the ...   more »

View Article  Molecule Linked disorder could lead to treatments for MS
Molecule May Drive Multiple Sclerosis Linked Disorder - Discovery could lead to treatments for transverse myelitis and MS

Researchers report that a single molecule called IL-6 is the cause
of ...   more »

View Article  efficacy of glatiramer acetate in beta-interferon-intolerant MS patients

The efficacy of glatiramer acetate in beta-interferon-intolerant MS patients.
Objectives - Glatiramer acetate (GA) is routinely used in multiple sclerosis (MS) patients who cannot tolerate or fail to respond to ...   more »